![Fredrik Conradi Schreuder](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Fredrik Conradi Schreuder
Voorzitter bij RespiNor AS
Profiel
Fredrik Conradi Schreuder is currently the Chairman at RespiNor AS and the Director at NeoRad AS.
He previously held positions as the Chairman at Algeta ASA and as the Senior Vice President at Hafslund Nycomed AS.
Actieve functies van Fredrik Conradi Schreuder
Bedrijven | Functie | Begin |
---|---|---|
NeoRad AS
![]() NeoRad AS Medical SpecialtiesHealth Technology NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway. | Directeur/Bestuurslid | - |
RespiNor AS
![]() RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Voorzitter | - |
Eerdere bekende functies van Fredrik Conradi Schreuder
Bedrijven | Functie | Einde |
---|---|---|
ALGETA ASA | Voorzitter | - |
Hafslund Nycomed AS | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
NeoRad AS
![]() NeoRad AS Medical SpecialtiesHealth Technology NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway. | Health Technology |
Hafslund Nycomed AS | Health Technology |
Algeta ASA
![]() Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
RespiNor AS
![]() RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Electronic Technology |